To: TrumpCards who wrote (3988 ) 6/6/1998 3:37:00 AM From: tfk Read Replies (1) | Respond to of 10343
<<LE good point they could have saved a TON of $$ by buying shares back in the sub $1. Maybe INFE Mgmt. is just as shocked as everybody else that their stock price is at these high levels. Doesn't say how many shares they are buying back or what funds the money will come from. Of course we don't even know how much cash they have.>> TrumpCards, if you had only read their latest press release, the answers are there: - current stock price is "significantly undervalued" - "to reach the goal of NASD Small Cap Market listing as soon as possible". One requirement is a minimum bid price of$4; so a stock buy back plan would help in this regard. - Company is currently in acquisition mode "until it has a minimum of $150 million in annualized revenues" [from www.info.com]. Notice the mention of "pending acquisitions" in the press release; news of some of these acquisitions may be out soon--next week perhaps?! Also, the following is from their web page: FINANCIAL PROJECTIONS (Revenues in Millions) Revenues over 5 year period: $150 - $500 Net profit - 2% to 4%: $3.0-$6.0 - $10.0 - $20.0 Estimated Earnings per share: $0.50-$0.60 - $1.00 - $2.00 Stock Price Range: $10.00 -$20.00 - $30.00 - $50.00 Industry Average P/E Ratio 1997 - 20 x earnings. TrumpCards, I obtained the above information in just about 5 minutes or less of research. If you were sincerely interested in INFE, you would have done the same and gotten your answers. As far as how much cash they have on hand, we would not know (except insiders) until the company becomes fully reporting, which they have plans to do. From their Jan. 28 press release (see web page), Tom Richfield, CEO, said they have "plans to become a reporting company by the end of the first quarter of 1998". Granted these reports are not out yet, as far as I know, but when they are then we would have a better picture of their financial situation. TrumpCards, from the tone of your posts I suggest you wait until their financials come out first and then re-evalute your investing in INFE. In the meantime, would you please leave this thread? Obviously, you are not willing to do your share of research to offer any constructive input to this thread. Regards, tfk